Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05YHW
|
||||
Former ID |
DIB008180
|
||||
Drug Name |
Vapaliximab
|
||||
Synonyms |
Huvap; HuvapR; BTT-1002; Chimeric VAP-1 monoclonal antibody (inflammation), BioTie; Chimeric VAP-1 mAb (inflammation), BioTie/Seikagaku
|
||||
Drug Type |
Antibody
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Terminated | [547592] | ||
Company |
BioTie Therapies Corp
|
||||
CAS Number |
CAS 336801-86-6
|
||||
Target and Pathway | |||||
Target(s) | Membrane copper amine oxidase | Target Info | [550071] | ||
PANTHER Pathway | Phenylethylamine degradation | ||||
PathWhiz Pathway | Beta-Alanine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.